These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6362962)

  • 1. [Clinical evaluation of a new choleretic administered in normal and high doses to patients with chronic hepatocholecytopathies].
    Petracca EG; Cavazzuti C
    Clin Ter; 1983 Oct; 107(2):109-19. PubMed ID: 6362962
    [No Abstract]   [Full Text] [Related]  

  • 2. [Double-blind clinical evaluation of choleretic agents in patients with chronic liver disease and cholestasis syndromes].
    Alkabes M; Ancona A; Palmieri R; Palmieri G; Zambruno E
    Clin Ter; 1980 Dec; 95(6):637-54. PubMed ID: 7011665
    [No Abstract]   [Full Text] [Related]  

  • 3. [Epomediol-induced modifications of the biohumoral picture in hepatic cirrhosis with or without cholestasis].
    Alberti A; Andreuzzi B; Santese R; Rotondo F
    Clin Ter; 1983 Feb; 104(3):227-33. PubMed ID: 6345051
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical study of an original synthetic choleretic: 3,4-methylenedioxycinnamic acid].
    Tacca GP
    Minerva Gastroenterol; 1974; 20(4):168-74. PubMed ID: 4459733
    [No Abstract]   [Full Text] [Related]  

  • 5. Ursodeoxycholic acid for terbinafine-induced toxic hepatitis.
    Agca E; Akcay A; Simsek H
    Ann Pharmacother; 2004 Jun; 38(6):1088-9. PubMed ID: 15122001
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experience in treatment of chronic toxic hepatitis by ursodeoxicholic acid].
    Agzamova GS
    Med Tr Prom Ekol; 2001; (1):39-42. PubMed ID: 11221110
    [No Abstract]   [Full Text] [Related]  

  • 7. [Xylitol as a choleretic and cholecystokinetic agent].
    Gruncharov V
    Vutr Boles; 1973; 12(2):69-73. PubMed ID: 4713058
    [No Abstract]   [Full Text] [Related]  

  • 8. [Study of an hepatic analeptic by enzyme determinations and hepatic clearance tests].
    Boisson J
    Ann Gastroenterol Hepatol (Paris); 1972; 8(2):191-6. PubMed ID: 5056542
    [No Abstract]   [Full Text] [Related]  

  • 9. [Imecromone: a new choleretic with antispastic action on Oddi's sphincter. Clinical pharmacology and clinico-statistical study].
    Cremoncini C; Tominz L
    Minerva Med; 1968 Oct; 59(82):4359-68. PubMed ID: 5683717
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of hepatophyt on the choleretic function of the liver damaged by tetracycline].
    Nikolaev SM; Sambueva ZG; Chekhirova GV; Tsyrenzhalov AV
    Antibiot Khimioter; 2003; 48(4):24-6. PubMed ID: 13677134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Controlled clinical evaluation of cicloxilic acid in hepatopathies caused by psychopharmacological agents].
    Bocci U; Beretta G
    Clin Ter; 1980 May; 93(4):373-88. PubMed ID: 6998639
    [No Abstract]   [Full Text] [Related]  

  • 12. [Controlled double-blind clinical study of cinnametic acid, a new choleretic agent in hepatobiliary diseases].
    Marchettini G; Maggi P; Benvenuti C
    Clin Ter; 1978 Sep; 86(5):485-94. PubMed ID: 367683
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacological treatment of cholestasis.
    Alvaro D
    Methods Find Exp Clin Pharmacol; 1996; 18 Suppl B():47-51. PubMed ID: 8899693
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of pecvocrine on the biligenic function of the liver in acute experimental hepatitis].
    Pasechnik IKh
    Farmakol Toksikol; 1973; 36(1):103-4. PubMed ID: 4685141
    [No Abstract]   [Full Text] [Related]  

  • 15. [Medical treatment of chronic cholestasis: ursodeoxycholic acid].
    Linares Rodríguez A
    Gastroenterol Hepatol; 2000 Feb; 23 Suppl 1():24-38. PubMed ID: 11968340
    [No Abstract]   [Full Text] [Related]  

  • 16. Intrahepatic cholestasis in acute viral hepatitis: a double-blind trial with dihydroxydibutylether in comparison with placebo.
    Marchettini G; Corsini P; Massimini G
    Drugs Exp Clin Res; 1987; 13(1):51-6. PubMed ID: 3297594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Oragallin purum, a new choleretic].
    Dierel HL
    Wien Med Wochenschr; 1965 Jul; 115(30):613-5. PubMed ID: 5319876
    [No Abstract]   [Full Text] [Related]  

  • 18. [Studies of the choleretic and liver-protective effects of the product, "Menabil Complex"].
    Gheorghescu B; Steflea D; Jovin G; Suseanu I
    Fiziol Norm Patol; 1973; 19(1):51-6. PubMed ID: 4266192
    [No Abstract]   [Full Text] [Related]  

  • 19. [Efficacy and tolerance of intravenously administered epomediol in patients with hepatopathy].
    Fiocchi G; Dieci MG; Fiorani F; Galvani V; Lissandrin MR; Martino P; Politi E; Sotti A; Carrara GC
    Clin Ter; 1988 Oct; 127(1):37-41. PubMed ID: 2976340
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical manifestation of hepatotoxic effect of cytostatic chemicals].
    Polunina TE; Maev IV
    Eksp Klin Gastroenterol; 2007; (3):52-4. PubMed ID: 17939196
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.